Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $8.3500 (-4.68%) ($8.3500 - $8.3500) on Mon. Apr. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.93% (three month average) | RSI | 35 | Latest Price | $8.3500(-4.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(48%) IBB(45%) ARKG(44%) ARKK(44%) XAR(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.465% in a week (0% probabilities). VIXM(-39%) VXX(-26%) UNG(-19%) USO(-10%) TLT(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.465% (StdDev 4.93%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $9.3 | 5 Day Moving Average | $8.98(-7.02%) | 10 Day Moving Average | $9.23(-9.53%) | 20 Day Moving Average | $9.3(-10.22%) | To recent high | -47.8% | To recent low | 0% | Market Cap | $620m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |